Telaglenastat + Talazoparib In Prostate Cancer

Clinical trial NCT04824937 · UNKNOWN

Trial details

NCT number: NCT04824937
Sponsor: Massachusetts General Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Cancer Metastatic

Start date: 2021-07-01
Primary completion: 2021-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.